Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis

Company Overview

Caliber Imaging & Diagnostics, Inc. develops optical imaging technologies for medical diagnostics and biomedical research. The company is best known for its VivaScope line of confocal microscopy systems, which are designed to provide real-time, cellular-level images of tissue without requiring a conventional biopsy for every examination.

Its products have been used primarily in dermatology and skin-cancer evaluation, as well as in pathology, clinical research, and pharmaceutical development. VivaScope systems are intended to help physicians and researchers examine tissue structure and cellular characteristics in vivo or in laboratory settings, supporting applications such as lesion assessment, treatment monitoring, and research into disease processes.

The company was formerly known as Lucid, Inc. and adopted the Caliber Imaging & Diagnostics name as it expanded its focus on diagnostic imaging. Publicly available information about its current leadership, operations, and geographic reach is limited.

Key Stats

• Today's Range: $0.0006 to $0.0006
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.05
• Volume: N/A
• Average Volume: 6,702 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:LCDX
• CIK: N/A
• Web: www.caliberid.com
• Phone: 585-239-9800
• Fax: N/A
• Employees: 28
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A